French experience with telemedicine in inflammatory bowel disease: a patients and physicians survey.
Journal
European journal of gastroenterology & hepatology
ISSN: 1473-5687
Titre abrégé: Eur J Gastroenterol Hepatol
Pays: England
ID NLM: 9000874
Informations de publication
Date de publication:
01 04 2022
01 04 2022
Historique:
pubmed:
4
12
2021
medline:
5
3
2022
entrez:
3
12
2021
Statut:
ppublish
Résumé
The use of telemedicine dramatically increased during the COVID-19 pandemic. We collected patients and physicians experience on telemedicine in the field of inflammatory bowel disease (IBD). We conducted a nationwide survey between September 2020 and January 2021. A self-administered questionnaire was sent to participants through mailing lists of the national patients' association and IBD expert groups. Overall, 300 patients and 110 gastroenterologists filled out the survey. On a 10 points scale of satisfaction with telemedicine, 60% of patients noted a score ≥8 and 52.7% of physicians ≥7. Patients and gastroenterologists felt that the duration of teleconsultations appeared to be shorter than in-person visits in 57.5 and 55.1% of cases, respectively. All participants agreed that telemedicine is appropriate in dedicated situations and not for flare-up consultations. For 55.1% of patients, quality of care was the same via telemedicine, whereas 51.4% of gastroenterologists believed they managed less well their patients. Lack of clinical examination being pointed out as the main limitation of telemedicine. Three-quarters of patients and gastroenterologists would agree to use telemedicine more often in the future. Patients and gastroenterologists were satisfied with telemedicine and would be willing to use it in the future. However, telemedicine does not replace in-person visits and should be discussed on a case-by-case basis.
Sections du résumé
BACKGROUND AND AIMS
The use of telemedicine dramatically increased during the COVID-19 pandemic. We collected patients and physicians experience on telemedicine in the field of inflammatory bowel disease (IBD).
METHODS
We conducted a nationwide survey between September 2020 and January 2021. A self-administered questionnaire was sent to participants through mailing lists of the national patients' association and IBD expert groups.
RESULTS
Overall, 300 patients and 110 gastroenterologists filled out the survey. On a 10 points scale of satisfaction with telemedicine, 60% of patients noted a score ≥8 and 52.7% of physicians ≥7. Patients and gastroenterologists felt that the duration of teleconsultations appeared to be shorter than in-person visits in 57.5 and 55.1% of cases, respectively. All participants agreed that telemedicine is appropriate in dedicated situations and not for flare-up consultations. For 55.1% of patients, quality of care was the same via telemedicine, whereas 51.4% of gastroenterologists believed they managed less well their patients. Lack of clinical examination being pointed out as the main limitation of telemedicine. Three-quarters of patients and gastroenterologists would agree to use telemedicine more often in the future.
CONCLUSION
Patients and gastroenterologists were satisfied with telemedicine and would be willing to use it in the future. However, telemedicine does not replace in-person visits and should be discussed on a case-by-case basis.
Identifiants
pubmed: 34860706
doi: 10.1097/MEG.0000000000002319
pii: 00042737-202204000-00006
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
398-404Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Références
Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn’s disease. Lancet 2017; 389:1741–1755.
Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet 2017; 389:1756–1770.
Lahat A, Shatz Z. Telemedicine in clinical gastroenterology practice: what do patients prefer? Therap Adv Gastroenterol 2021; 14:1756284821989178.
Kernebeck S, Busse TS, Böttcher MD, Weitz J, Ehlers J, Bork U. Impact of mobile health and medical applications on clinical practice in gastroenterology. World J Gastroenterol 2020; 26:4182–4197.
Patil SA, Cross RK. Current landscape of telemedicine practice in inflammatory bowel disease. Inflamm Bowel Dis 2018; 24:1910–1917.
Jackson BD, Gray K, Knowles SR, De Cruz P. EHealth technologies in inflammatory bowel disease: a systematic review. J Crohns Colitis 2016; 10:1103–1121.
Krier M, Kaltenbach T, McQuaid K, Soetikno R. Potential use of telemedicine to provide outpatient care for inflammatory bowel disease. Am J Gastroenterol 2011; 106:2063–2067.
de Jong MJ, van der Meulen-de Jong AE, Romberg-Camps MJ, Becx MC, Maljaars JP, Cilissen M, et al. Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial. Lancet 2017; 390:959–968.
Cross RK, Langenberg P, Regueiro M, Schwartz DA, Tracy JK, Collins JF, et al. A Randomized Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD). Am J Gastroenterol 2019; 114:472–482.
Bonnaud G, Haennig A, Altwegg R, et al. Real-life pilot study on the impact of the telemedicine platform EasyMICI-MaMICI® on quality of life and quality of care in patients with inflammatory bowel disease. Scand J Gastroenterol 2021; 56:530–536.
Aguas Peris M, Del Hoyo J, Bebia P, Faubel R, Barrios A, Bastida G, et al. Telemedicine in inflammatory bowel disease: opportunities and approaches. Inflamm Bowel Dis 2015; 21:392–399.
Siegel CA. Transforming gastroenterology care with telemedicine. Gastroenterology 2017; 152:958–963.
Cross RK, Kane S. Integration of telemedicine into clinical gastroenterology and hepatology practice. Clin Gastroenterol Hepatol 2017; 15:175–181.
Lewin S, Lees C, Regueiro M, Hart A, Mahadevan U. International Organization for the study of inflammatory bowel disease: global strategies for telemedicine and inflammatory bowel diseases. J Crohns Colitis 2020; 14:S780–S784.
A. 1 Août 2018, NOR: SSAS1821639A. Arrêté Du 1er Août 2018 Portant Approbation de l’avenant N° 6 à La Convention Nationale Organisant Les Rapports Entre Les Médecins Libéraux et l’assurance Maladie Signée Le 25 Août 2016. JORF n°0183 du 10 août 2018. Accessed on March 2021. https://www.legifrance.gouv.fr/loda/id/JORFTEXT000037306389/
Fantini MC, Biancone L, Dragoni G, Bezzio C, Miranda A, Ribaldone DG, et al. Telemedicine and remote screening for COVID-19 in inflammatory bowel disease patients: results from the SoCOVID-19 Survey. Inflamm Bowel Dis 2020; 26:e134–e136.
Perisetti A, Goyal H. Successful distancing: telemedicine in gastroenterology and hepatology during the COVID-19 pandemic. Dig Dis Sci 2021; 66:945–953.
Lees CW, Regueiro M, Mahadevan U; International Organization for the Study of Inflammatory Bowel Disease. Innovation in inflammatory bowel disease care during the COVID-19 pandemic: results of a Global Telemedicine Survey by the International Organization for the Study of Inflammatory Bowel Disease. Gastroenterology 2020; 159:805–808.e1.
Téléconsultation et Covid-19 : croissance spectaculaire et évolution des usages. Accessed on March 2021. https://www.ameli.fr/medecin/actualites/teleconsultation-et-covid-19-croissance-spectaculaire-et-evolution-des-usages
Polinski JM, Barker T, Gagliano N, Sussman A, Brennan TA, Shrank WH. Patients’ satisfaction with and preference for telehealth visits. J Gen Intern Med 2016; 31:269–275.
Soegaard Ballester JM, Scott MF, Owei L, Neylan C, Hanson CW, Morris JB. Patient preference for time-saving telehealth postoperative visits after routine surgery in an urban setting. Surgery 2018; 163:672–679.
de Jong MJ, Boonen A, van der Meulen-de Jong AE, Romberg-Camps MJ, van Bodegraven AA, Mahmmod N, et al. Cost-effectiveness of telemedicine-directed specialized vs standard care for patients with inflammatory bowel diseases in a randomized trial. Clin Gastroenterol Hepatol 2020; 18:1744–1752.
Li SX, Thompson KD, Peterson T, Huneven S, Carmichael J, Glazer FJ, et al. Delivering high value inflammatory bowel disease care through telemedicine visits. Inflamm Bowel Dis 2017; 23:1678–1681.
Munroe CA, Lin TY, Rouillard S, Fox J, Lee JK, Corley DA. Influence of telemedicine-first intervention on patient visit choice, postvisit care, and patient satisfaction in gastroenterology. Gastroenterology 2021; 160:929–931.e2.